DB
MYGN icon

Dmitry Balyasny’s Myriad Genetics MYGN Stock Holding History

Dmitry Balyasny’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-624,000
Closed -$14.5M – 2562
2023
Q2 		$14.5M Buy
624,000
+72,400
+13% +$1.58M 0.03% 642
2023
Q1 		$12.8M Buy
+551,600
New +$11.2M 0.03% 683
2014
Q2 		– Sell
-50,000
Closed -$1.71M – 727
2014
Q1 		$1.71M Buy
+50,000
New +$1.55M 0.02% 482
2013
Q4 		– Sell
-11,428,400
Closed -$24M – 584
2013
Q3 		$24M Buy
+11,428,400
New +$325M 0.32% 69

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dmitry Balyasny's MYGN Position: Q2 2026 in Review

Dmitry Balyasny opened a new position in Myriad Genetics (MYGN) in Q2 2026: 36,860 shares worth $210K. The stake represents ﹤0.01% of the portfolio and ranks #2812 among its holdings. This is a return to the name: Dmitry Balyasny previously reported a position in MYGN as recently as Q4 2025.

Dmitry Balyasny first reported a position in MYGN in Q4 2016 and has held it in 21 quarters since. The position peaked at $36.9M in Q1 2023. 195 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • Dmitry Balyasny held 36,860 shares of Myriad Genetics worth $210K as of Q2 2026.
  • Myriad Genetics was a new Dmitry Balyasny position in Q2 2026.
  • Myriad Genetics made up ﹤0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #2812 holding.
  • Dmitry Balyasny first reported a position in Myriad Genetics in Q4 2016 and has held it in 21 quarters since.
  • Dmitry Balyasny's Myriad Genetics position peaked at $36.9M in Q1 2023.
  • 195 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.